Trials / Unknown
UnknownNCT02458781
Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth
Antibiotic Treatment Trial for Small Intestinal Bacterial Overgrowth: A Randomized, Double-Blind, Placebo-Controlled Trial Comparing Ciprofloxacin and Metronidazole
- Status
- Unknown
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 180 (estimated)
- Sponsor
- San Antonio Military Medical Center · Federal
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, double-blind, placebo-controlled study to evaluate the efficacy of ciprofloxacin versus metronidazole versus placebo in eradication of small intestinal bacterial overgrowth (SIBO).
Detailed description
Approximately 180 study subjects with SIBO identified by positive glucose hydrogen breath (GHB) testing who meet inclusive and exclusive criteria will be randomized to receive either ciprofloxacin 500mg by mouth twice daily, metronidazole 500mg by mouth twice daily, or placebo by mouth twice daily. Subjects will complete a baseline symptom questionnaire and be treated for 14 days. Response will be assessed at end of treatment. The Gastrointestinal Symptom Rating Scale (GSRS) and GHB testing will be performed at the end of treatment. Subjects with a negative GHB at the end of treatment are considered as cured, or treatment success. Patients with treatment success will be reassessed for long-term response to treatment or disease recurrence at 30 days, 4 months, and 9 months using GHB. Symptoms will also be re-assessed at the 30 day, 4 month, and 9 month intervals with GSRS-IBS symptom questionnaire done prior to GHB testing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Metronidazole | Metronidazole 500mg given twice daily for 14 days |
| DRUG | Ciprofloxacin | Ciprofloxacin 500mg given twice daily for 14 days |
| DRUG | Placebo | Placebo given twice daily for 14 days |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2018-01-01
- Completion
- 2018-06-01
- First posted
- 2015-06-01
- Last updated
- 2015-06-01
Source: ClinicalTrials.gov record NCT02458781. Inclusion in this directory is not an endorsement.